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Abstract: A common technique to aid in implant ﬁ  xation into surrounding bone is to inject 
bone cement into the space between the implant and surrounding bone. The most common 
bone cement material used clinically today is poly(methyl methacrylate), or PMMA. Although 
promising, there are numerous disadvantages of using PMMA in bone ﬁ  xation applications 
which has limited its wide spread use. Speciﬁ  cally, the PMMA polymerization reaction is highly 
exothermic in situ, thus, damaging surrounding bone tissue while curing. In addition, PMMA 
by itself is not visible using typical medical imaging techniques (such as X-rays required to 
assess new bone formation surrounding the implant). Lastly, although PMMA does support 
new bone growth, studies have highlighted decreased osteoblast (bone forming cell) functions 
on PMMA compared to other common orthopedic coating materials, such as calcium phos-
phates and hydroxyapatite. For these reasons, the goal of this study was to begin to investigate 
novel additives to PMMA which can enhance its cytocompatibility properties with osteoblasts, 
decrease its exothermic reaction when curing, and increase its radiopacity. Results of this study 
demonstrated that compared to conventional (or micron) equivalents, PMMA with nanoparticles 
of MgO and BaSO4 reduced harmful exothermic reactions of PMMA during solidiﬁ  cation and 
increased radiopacity, respectively. Moreover, osteoblast adhesion increased on PMMA with 
nanoparticles of MgO and BaSO4 compared with PMMA alone. This study, thus, suggests that 
nanoparticles of MgO and BaSO4 should be further studied for improving properties of PMMA 
for orthopedic applications.
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Introduction
The long-term success of total joint replacements is largely dependent upon the incor-
poration of the implant with healthy surrounding bone tissue (ie, osseointegration). A 
common technique to aid in implant ﬁ  xation into surrounding bone is to inject bone 
cement into the space between the implant and surrounding bone (Kuhn 2000). Such 
bone cements have been developed to be injected in liquid form and then solidify to 
mediate the attachment of the implant to bone.
The most common bone cement material used clinically today is poly(methyl 
methacrylate), or PMMA (Li et al 1995; Scripitz and Aspenberg 1999; Kuhn 2000). 
It is prepared at the clinical bed side by mixing PMMA powder, an initiator, and a 
monomer liquid, methyl methacrylate (MMA). Creating PMMA bone cement is analo-
gous to mixing epoxy for daily use. Once mixed, the cement is liquid and, thus, can 
easily cover the implant after injection. PMMA continues to polymerize and cures in 
the empty space between the implant and bone providing stability to the implant.
Although promising, there are numerous disadvantages of using traditional PMMA 
in bone ﬁ  xation applications which has limited its wide spread use. Speciﬁ  cally, the 
PMMA polymerization reaction is highly exothermic (as high as 80 °C in some cases) in 
situ, thus, damaging surrounding bone tissue (Biehl et al 1974; Fukushima et al 2002). International Journal of Nanomedicine 2008:3(1) 126
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In addition, PMMA is not visible using typical medical 
imaging techniques (such as X-rays required to assess new 
bone formation surrounding the implant). Thus, to monitor 
new bone growth surrounding PMMA after insertion, the 
radiopacity of PMMA can be increased by adding a common 
contrast agent (such as barium sulfate [BaSO4]) (Ginebra 
et al 2002). However, there are limitations on the amount of 
BaSO4 that can be added to PMMA since BaSO4 has been 
shown to adversely affect the mechanical and biocompat-
ibility properties of PMMA at high concentrations (Bhambri 
et al 1995; Ginebra et al 2002). Lastly, although PMMA 
does support new bone growth, studies have highlighted 
decreased osteoblast (bone forming cell) functions on PMMA 
compared with other common orthopedic coating materials, 
such as calcium phosphates and hydroxyapatite (Glimcher 
1987; Gauthier et al 1999; Barralet et al 2004; Gbureck et al 
2004; Lilley et al 2005).
The goal of this study was to begin to investigate novel 
additives to PMMA which can enhance its cytocompatibility 
properties with osteoblasts, decrease its exothermic reaction 
when curing, and increase its radiopacity. Due to increased 
surface area, it is theorized here that nanoparticles of MgO 
may reduce exothermic reactions of polymers compared to 
micron particles of MgO and other chemistries. Moreover, 
while micron particles of BaSO4 are common additives to 
PMMA, researchers have hypothesized that due to increased 
surface area, nanoparticles of BaSO4 can improved X-ray 
contrast properties of PMMA (Wei and Ma 2004). Lastly, 
numerous studies have emerged demonstrating greater in 
vitro and in vivo bone growth on polymer composites con-
taining nanoparticles (summarized in Liu et al 2005 and Liu 
and Webster 2007). Thus, PMMA with nanoparticles of MgO 
and BaSO4 may not only reduce heat released during PMMA 
solidiﬁ  cation and enhance X-ray radiopacity, respectively, 
but they both may also simultaneously enhance osteoblast 
functions. For these reasons, the present study separately 
added MgO and BaSO4 nanoparticles to PMMA in an effort 
to improve its properties for orthopedic applications.
Materials and methods
PMMA cement preparation
Methyl methacrylate (MMA) was purchased from Polysciences 
(Warrington, PA). In order to create bone cement samples with-
out any additives, ﬁ  ve grams of MMA beads were added to an 
initiator (benzoyl peroxide; Sigma). For some of the samples, 
10 percent (w/w) of the selected additives in conventional (or 
micron) and nanometer particulate form were added into the 
dissolved PMMA (Table 1). These additives, MgO and BaSO4, 
were purchased from Sigma-Aldrich (St. Louis, MO) and Reade 
Materials (Providence, RI), respectively (Table 2). Once the 
MMA beads were added to an initiator, they were allowed to 
solidify for 1 day. Prior to testing, all PMMA cements were 
sterilized by soaking in ethanol (5 minutes).
PMMA characterization
Scanning electron microscopy and atomic force 
microscopy
To visualize the micron and nanoparticles of MgO and BaSO4 
in the various PMMA samples, scanning electron microscopy 
(SEM) and atomic force microscopy (AFM) were used. 
Samples were mounted on stubs and sputter-coated with 
gold prior to examination using a Leo 1530-VP scanning 
electron microscope. To provide quantitative evidence of 
the difference in surface roughness, the substrates were also 
examined by AFM (Nanoscope IIIa, Veeco, CA) with scan 
areas of 1 µm × 1 µm. Commercially available AFM tips 
(radius of tip curvature was less than 10 nm, NSC15/ALBS, 
Micro-Masch, OR) were used in tapping mode. All roughness 
values (RMS or root mean square) were measured at least 
three times on each substrate and were repeated three times 
using installed software (Nanoscope 4.42, Veeco, CA).
Exothermic measurement
The change in temperature of the PMMA samples during 
solidiﬁ  cation was determined by using a 4-channel DI-1000 
thermocouple (DATAQ Instruments). Type T thermocouple 
leads (copper/constantan, 0.1 °C accuracy) were placed into 
Table 1 Chemical composition of the PMMA bone cements of interest to the present study
Groups  PMMA   Conventional MgO  Nanoscale MgO  Conventional BaSO4 Nanoscale  BaSO4
Group 1  5 g  –  –  –  –
Group 2  4.5 g  0.5 g  –  –  –
Group 3  4.5 g  –  0.5 g  –  –
Group 4  4.5 g  –  –  0.5 g  –
Group 5  4.5 g  –  –  –  0.5 g
Abbreviation: PMMA, poly(methyl methacrylate).International Journal of Nanomedicine 2008:3(1) 127
The inﬂ  uence of nano MgO and BaSO4
the PMMA samples and the temperature change was recorded 
over various periods of time until the PMMA completely 
hardened. The temperature of pure PMMA cement at time 
zero was used as background recording. This temperature 
was subtracted from recorded temperatures for each type of 
PMMA cement at 1 second, 1 minute, 2 minutes, 10 minutes 
and at the end of recording (1 hour and 47 minutes).
Radiopacity
X-ray images of the various PMMA cement samples were 
taken after they solidiﬁ  ed with an X-ray machine (General 
Electric) using a digital detector (40 kV, 63 mA, in air). 




Human osteoblasts (CRL-11372) were obtained from the 
American Type Culture Collection (ATCC) and were used 
at population numbers up to 3. Osteoblasts were cultured 
according to ATCC instructions in Dulbecco’s modiﬁ  ed 
Eagle medium (DMEM; Gibco) supplemented with 10% 
fetal bovine serum (FBS; Hyclone) and 1% penicillin/strep-
tomycin (P/S; Hyclone) under standard cell culture conditions 
(37 °C, humidiﬁ  ed, 5% CO2/95% air environment).
Adhesion assay and ﬂ  uorescence microscopy
Osteoblasts were seeded (3500 cells/cm2) in DMEM supple-
mented with 10% FBS and 1% P/S onto the substrates of 
interest to the present study and were placed in standard cell 
culture conditions for 4 hours. After 4 hours, nonadhered 
cells were removed by rinsing several times with phos-
phate-buffered saline (PBS). Adherent cells were then ﬁ  xed 
with 4% formalin in PBS and their nuclei were stained with 
DAPI (Sigma). Cells were counted in ﬁ  ve random ﬁ  elds 
per substrate and images were taken using a Zeiss Axiovert 
200M light microscope (10 X objective) with image analysis 
software (Axiovision). The adhesion experiments were run 
in triplicate and repeated at least three different times per 
substrate.
Statistical analysis
Cell density (cells/mm2) on the substrates of interest were 
analyzed statistically using standard analysis of variance 
(ANOVA) techniques; statistical signiﬁ  cance was considered 
at p  0.05.
Results
Scanning electron microscope images 
and atomic force microscopy data 
of PMMA cements
SEM images and AFM data provided evidence that pure 
PMMA possessed a very smooth surface with little to no micron 
and nanometer roughness (Figure 1 and Table 3). In contrast, 
the PMMA samples which contained either BaSO4 or MgO 
exhibited increased surface roughness. PMMA that contained 
nanophase particles possessed greater micron and nanometer 
roughness as compared to those with conventional particles.
Reduced exothermic reaction for PMMA 
with nano MgO
Results of the present study demonstrated that PMMA 
samples which contained either BaSO4 or MgO (conventional 
or nanophase) exhibited lower increases in temperatures 
compared with pure PMMA while curing (Table 4). The 
drop in temperature was the most dramatic during the ﬁ  rst 
10 minutes of recording. More importantly, the PMMA 
sample which contained nanoparticles of MgO had the small-
est temperature increase compared to any of the samples in 
this study. Speciﬁ  cally, compared to plain PMMA, PMMA 
with nanoparticles of MgO had −5.31 °C, −5.46 °C, −4.01 °C, 
−3.65 °C, and −2.95 °C temperature changes after 1 second, 
1 minute, 2 minutes, 10 minutes, and 1 hour and 47 minutes 
of mixing, respectively. The temperature of PMMA after 
1 second, 1 minute, 2 minutes, 10 minutes, and 1 hour 
and 47 minutes of mixing was 44.98 °C, 45.82 °C, 50.1 °C, 
52.5 °C, and 47.85 °C, respectively.
Increased radiopacity of PMMA cements 
with nano BaSO4
Results of this study further demonstrated that PMMA with 
nanoparticles of BaSO4 were more radiopaque than those with 
microparticles (Table 5). As expected, PMMA with either nano-
meter or micron particles of BaSO4 possessed increased X-ray 
intensity compared to PMMA alone. X-ray images showed that 
the order of the X-ray intensities of the samples were (ﬁ  rst being the 
highest intensity): nanophase BaSO4  conventional BaSO4  
nanophase MgO  conventional MgO  pure PMMA.
Table 2 Particulate size of PMMA additives
Bone cement additive  Particulate size (Diameter)
Conventional MgO   12 µm 
Nanoscale MgO   12.8 nm
Conventional BaSO4   2 µm
Nanoscale BaSO4   80–500 nm
Abbreviation: PMMA, poly(methyl methacrylate).International Journal of Nanomedicine 2008:3(1) 128
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Figure 1 SEM images of PMMA with nano BaSO4 or nano MgO. 
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Increased osteoblast adhesion on PMMA 
with nano MgO and BaSO4
Lastly, results of this study demonstrated that the PMMA 
cement samples with nanophase MgO and nanophase BaSO4 
had higher cell densities than the pure PMMA cement 
samples (p  0.1) (Figures 2 and 3). Interestingly, while 
osteoblast adhesion was greater on PMMA with nanophase 
compared to conventional MgO, it was similar on PMMA 
with nanophase compared to conventional BaSO4. Moreover, 
the PMMA cement samples with conventional BaSO4 had 
a signiﬁ  cantly higher cell density than those with conven-
tional MgO.
Discussion
PMMA possesses attractive properties for orthopedic appli-
cations, but it has three major drawbacks. The ﬁ  rst shortcom-
ing of PMMA is its strong exothermic properties from its 
monomer methyl methacrylate (MMA). A signiﬁ  cant amount 
of heat is produced when MMA polymerizes. In vitro testing 
of pure MMA demonstrated that the temperature can reach 
up to 100 °C. Because of this tremendous heat release, the 
composition of commercial bone cement has been modiﬁ  ed 
to have polymer/monomer ratios of 2/1 (w/w) which ensures 
less heat release and a smaller volume change (Kuhn 2000). 
However, the temperature at the bone-cement interface is 
still above the physiological range (43 ~ 46 °C), which could 
cause surrounding tissue death (Kuhn 2000).
Magnesium oxide (MgO) is a ceramic that has seldom 
been used in the orthopedic industry due to its poor mechani-
cal properties possesses. However, nanoparticles of MgO 
could potentially reduce heat generation since the overall 
surface area and dispersion of such nanoparticles is much 
higher than that of micron-sized particles. That is, by expos-
ing more surface area, nanoparticles in general can decrease 
exothermic reactions of bone cements. This was conﬁ  rmed 
in the current study where it was found that PMMA cement 
samples which contained either MgO (or BaSO4) dra-
matically decreased temperature increases during PMMA 
solidiﬁ  cation. Importantly, the temperature drops were sig-
niﬁ  cantly larger when nanoparticles were present instead of 
conventional (or micron-sized) particles.
Another disadvantage of PMMA as an orthopedic mate-
rial is its radiolucency (Bhambri et al 1995; Ginebra et al 
2002). Since X-rays are used to monitor the bone healing 
process, identifying osteolytic lesions around an implant, 
and detecting fractures in the bone cement after surgery, 
radiolucent PMMA cements presents a challenge. Con-
ventionally, two heavy metal ion salts (barium sulfate or 
zirconium dioxide (ZrO2) have been added to bone cements 
to increase its X-ray contrast; both in micron particle form 
(Bhambri et al 1995; Ginebra et al 2002). However, adding 
micron sized metal ions adversely affects the biological 
and mechanical properties of PMMA (Bhambri et al 1995; 
Ginebra et al 2002). For example, micron-sized particles of 
BaSO4 decreased the tensile strength of bone cements from 
45 MPa to 36 MPa (Ginebra et al 2002). BaSO4 micron 
agglomerates serve as initiation sites for fatigue cracks. It 
has also been found that PMMA wear particles that contain 
micron-sized BaSO4 and ZrO2 particles cause more bone 
resorption than pure PMMA wear particles; this has lead 
to increased osteolysis when micron-sized BaSO4 and ZrO2 
particles are used in PMMA (Liu-Synder and Webster 2007). 
In addition, although more testing is needed, recent studies 
have demonstrated less adverse reactions of ceramic nanopar-
ticulate compared to micron wear debris (Liu-Synder and 
Table 3 AFM surface roughness of PMMA cements
PMMA bone cement sample  AFM RMS (nm) obtained 
  through 1 by 1 µm AFM scans
Plain PMMA  0
PMMA with conventional MgO   1.2 
PMMA with nanoscale MgO   25.9 
PMMA with conventional BaSO4   4.2
PMMA with nanoscale BaSO4   42.1 
Abbreviations: AFM, atomic force microscopy; PMMA, poly(methyl methacrylate).
Table 4 Decreased PMMA exothermic reaction with nano MgO (∆T °C compared to time after curing of PMMA alone)
Sample  1 sec  1 min  2 min  10 min  1hr 47 min
PMMA + 10 wt% conventional MgO  −1.65 °C**  −1.96 °C**  −1.81 °C**  −1.50 °C**  −0.45 °C**
PMMA + 10 wt% nanophase MgO  −5.31 °C*,**  −5.46 °C*,**  −4.01 °C*,**  −3.65 °C*,**  −2.95 °C*,**
PMMA + 10 wt% conventional BaSO4 0  °C  −0.60 °C  −0.45 °C  −0.15 °C  −0.15 °C
PMMA + 10 wt% nanophase BaSO4  −0.15 °C*  −1.20 °C*,**  −1.05 °C*,**  −0.30 °C*  −0.15 °C
Notes: *p  0.01 (compared with respective conventional additive) and **p  0.01 (compared with PMMA alone).
Abbreviation: PMMA, poly(methyl methacrylate).International Journal of Nanomedicine 2008:3(1) 130
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Webster 2007). Therefore, the present study investigated the 
possibility of replacing micron with nanoparticles of BaSO4. 
X-ray images of PMMA cement samples showed that the 
highest radiopacity was obtained when using nanoparticles 
compared to micron particles of BaSO4. Any improvements 
in X-ray image contrast will not only shorten hospital stay but 
also reduce a patients’ exposure to X-rays. X-ray exposure 
has been linked to increased risk of cancer (Liu-Synder and 
Webster 2007), thus, increased radiopacity of bone cements 
will allow for a reduced patients’ exposure to X-rays and 
consequently lead to a lower incidence of cancer.
Lastly, the most challenging issue associated with com-
mercially available PMMA cements is their poor osseo-
integration (Glimcher 1987; Gauthier et al 1999; Barralet 
et al 2004; Gbureck et al 2004; Lilley et al 2005). PMMA 
additives (such as antibiotics and radiopaciﬁ  ers) have been 
shown in the past to adversely affect osseointegration (Liu-
Synder and Webster 2007). Therefore, whenever a new 
material is added into PMMA, the resulting PMMA cements 
should be tested for cytocompatibility properties. Results 
of the present study demonstrated that osteoblast adhesion 
was higher on PMMA cements with either nanophase MgO 
or conventional and nanophase BaSO4 than pure PMMA 
cement. Results of improved osteoblast adhesion on PMMA 
with nanometer compared to micron particles of MgO con-
ﬁ  rms that of other studies which have shown greater osteo-
blast functions on nanometer compared with conventional 
ceramics, metals, polymers, and composites (Liu-Synder 
and Webster 2007). However, future investigations will be 
needed to elucidate why greater osteoblast adhesion was not 
observed on nanometer compared with micron BaSO4 added 
to PMMA. Perhaps sonication or other processing conditions 
will have to be modiﬁ  ed to amplify the degree of nanometer 
roughness when using nanoparticles of BaSO4 in PMMA. 
Previous studies have shown greater dispersion of nanopar-
ticles in polymers promotes osteoblast functions (Liu-Synder 
and Webster 2007). Furthermore, although osteoblast adhe-
sion is a prerequisite for mineral deposition, longer-term 
functions of osteoblasts will have to be determined on the 
PMMA samples of interest to this study.
In the current study, the additives (MgO an BaSO4) 
were used at 10% (w/w) per total PMMA cement. Little 
information is known about the optimal composition for 
both MgO and BaSO4 in PMMA and this needs to be further 
investigated. In addition, the current study was performed 
when MgO and BaSO4 were added separately to PMMA. It 
Table 5 Increased radiopacity of PMMA with nano BaSO4
Sample X-ray  intensity  (%) 
PMMA + 10 wt% conventional MgO  0.4
PMMA + 10 wt% nanophase MgO  0.5
PMMA + 10 wt% conventional BaSO4 12.5**
PMMA + 10 wt% nanophase BaSO4 35.9*,**
Notes: *p  0.01 (compared with respective conventional additive) and **p  0.01 
(compared with PMMA alone). X-rays taken with a digital detector (40 kV, 63 mA, in air).
Abbreviation: PMMA, poly(methyl methacrylate).
Figure 2 Increased osteoblast adhesion on PMMA with either nano MgO or conventional/nano BaSO4. Data = mean ± SEM; n = 3; ∆ p  0.1 (compared to PMMA alone 
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is intriguing to ponder whether PMMA cement with both 
nano MgO and nano BaSO4 would combine the beneﬁ  ts 
of reduced exothermic reaction, increased radiopacity, and 
greater osteoblast functions.
Importantly, there are also other examples in the 
literature of using nanoparticles in PMMA to improve 
bone cement properties. For example, nano sized alumina 
and titania powder ﬁ  lled PMMA cements have improved 
mechanical properties compared to commercial PMMA 
cements (Liu-Snyder and Webster 2007). In addition, (5 
% wt) nanophase alumina-PMMA composites (alumina 
nanoparticles were coated with a layer of (3-acryloxy-
propyl) dimethylmethoxysilane (Gelest Inc.) before they 
were mixed and sonicated with MMA) exhibited a 28% 
increased tensile strength over pure PMMA (Liu-Snyder 
and Webster 2007). Also, the thermal conductivity of 
polymer-carbon nanotube (CNT) composites increased 
2.5-fold with the presence of a small amount of CNTs (1% 
v/v) (Liu-Snyder and Webster 2007). CNT ﬁ  llers can also 
help PMMA cements achieve better mechanical properties 
and promote bone cell growth and functions (Liu-Snyder 
and Webster 2007).
In summary, Lee and colleagues claimed in 1977 that 
“for the immediate future, reﬁ  nements in the technical use of 
[bone] cements are likely to prove more fruitful than changes 
in the cement itself” (Liu-Synder and Webster 2007). Over 
the last few decades, many modiﬁ  cations have been made 
to bone cements. But as our knowledge of nanotechnology 
expands exponentially, we envision a breakthrough in bone 
cement properties which will ensure long-term survival of 
joint implants in the body.
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